Differential expression of HLA-A*02 subtypes in Colombian blacks and Mestizos

Tissue Antigens

Volumn 51, Issue 2, 1998, Pages 204-209

  Fleischhauer, K ^a   Zino, E ^a   Arevalo Herrera, M ^b   Herrera, S ^b   Valmori, D ^c   Cerottini, J C ^c   Benazzi, E ^a   Bordignon, C ^a   Romero, P ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

A*0222; Colombian Mestizos; Colombians Black; PCR SSOP

Indexed keywords

HLA A2 ANTIGEN;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; COLOMBIA; CONTROLLED STUDY; ETHNIC GROUP; HUMAN; HUMAN CELL; NEGRO; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0031985982     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02966.x     Document Type: Article

References (33)

1. Imanishi I, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed., HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Oxford: Oxford University Press, 1992: 1065-220.
2. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens: 1997: 49: 297-321.
3. Yang SY. Population analysis of class I HLA antigens by one-dimensional isoelectric focusing gel electrophoreses: workshop summary report. In: Dupont B, ed. Immunobiology of HLA, Vol. I: Histocompatibility Testing 1987. New-York: Springer-Verlag, 1989: 54-5.
4. Krausa P, Brywka III M, Savage D et al. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995: 45: 223-31.
5. Fernandez-Vina MA, Falco M, Sun Y, Stastny P. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum Immunol 1992: 33: 163-73.
6. Tiercy JM, Djavad N, Rufer N, Speiser D, Jeannet M, Roosnek E. Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors. Hum Immunol 1994: 41: 207-15.
7. Fleischhauer K, Zino E, Mazzi B, Severini GM, Benazzi E, Bordignon C. HLA-A*02 subtype distribution in Caucasians from Northern Italy: Identification of A*0220. Tissue Antigens 1996: 48: 673-9.
8. Barouch D, Friede T, Stevanovic S et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 1995: 182: 1847-56.
9. Sudo T, Kamikawaji N, Kimura A et al. Differences in MHC class I self-peptide repertoires among HLA-A2 subtypes. J Immunol 1995: 155: 4749-56.
10. Roetzschke O, Falk K, Stevanovic S, Jung G, Rammensee HG. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol 1992: 22: 2453-56.
11. Tanigaki N, Fruci D, Chersi A, Falasca G, Tosi R, Butler RH. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol 1994: 39: 155-62.
12. del Guercio MF, Sidney J, Hermanson G et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995: 154: 685-93.
13. McMichael AJ, Gotch FM, Santos-Aguado J, Strominger JL. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 1988: 85: 9194-8.
14. Moots RJ, Matsui M, Pazmany L, McMichael AJ, Frelinger JA. A cluster of mutations in HLA-A2 α2 helix abolishes peptide recognition by T cells. Immunogenetics 1991: 34: 141-8.
15. Rivoltini L, Loftus DJ, Barracchini K et al. 1996. Binding and presentation of peptides derived from melanoma antigens MART-1 and Glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. J Immunol 1996: 156: 3882-91.
16. + cytotoxic T cell line. J Immunol 1996: 157: 787-97.
17. Fleischhauer K, Tanzarella S, Russo V et al. Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3 encoded peptide to cytotoxic T cell clones. J Immunol. In press 1997.
18. Mattson DH, Shimojo N, Cowan EP et al. Differential effects of amino acid substitutions in the β-sheet floor and α-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. J Immunol 1989: 143: 1101-7.
19. Matsui M, Moots RJ, Warburton RJ, Peace-Brewer AL et al. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. J Immunol 1995: 154: 1088-96.
20. Santos-Aguado J, Crimmins MAV, Mentzer SJ, Burakoff SJ, Strominger JL. Alloreactivity studied with mutants of HLA-A2. Proc Natl Acad Sci U S A 1989: 86: 8936-40.
21. Hogan KT, Clayberger C, Bernhard EJ et al. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes. J Immunol 1989: 142: 2097-2104.
22. Gonzalez JM, Olano V, Vergara J et al. Unstable, low-level transmission of malaria on the Colombian Pacific Coast. Ann Trop Med Parasitol 1997: 91: 349-58.
23. Parham P, Brodsky FM. Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981: 3: 277-84.
24. Oh S, Fleischhauer K, Yang SY. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens 1993: 41: 135-42.
25. Zino E, Severini GM, Mazzi B, Bordignon C, Benazzi E, Fleischhauer K. Sequencing of a new subtype of HLA-A*32 (A*3202). Immunogenetics 1996: 45: 76.
26. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977: 74: 5463-7.
27. Bjorkman PJ, Saper MA, Samaroui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987: 329: 506-12.
28. Bjorkman PJ, Saper MA, Samaroui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen-binding site and T-cell recognition regions of class I histocompatibility antigens. Nature 1987: 329: 512-8.
29. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A Resolution. J Mol Biol 1991: 219: 277-319.
30. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone-marrow allograft rejection by cytotoxic T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990: 323: 1818-22.
31. Keever CA, Leong N, Cunningham I et al. HLA-B44-directed cytotoxic T cells associated with acute graft versus host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994: 14: 134-45.
32. Arnett KL, Parham P. HLA class I nucleotide sequences, 1995. Tissue Antigens 1995: 45: 217-57.
33. Browning M, Krausa P. Genetic diversity of HLA-A2: evolutionary and functional significance. Immunol Today 1996: 17: 165-70.